LataMed AI is trading 15.39% down at $0.26, with no identified company-specific catalyst.
- No company-specific announcement dated September 16, 2026, was identified to explain the move.
- Declines extend from September 14 and September 11. The latest disclosed news, a September 9 cooperation agreement involving Venezuelan ministries and planned healthcare-technology deployment, does not establish a direct catalyst.
- Broader markets are mixed to positive; volume and activity details were unavailable.